Rajeev M. Shah Insider Trading $EIDX Eidos Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rajeev M. Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rajeev M. Shah. Rajeev M. Shah is Director in KalVista Pharmaceuticals, Inc. ($CBYL) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX).
Rajeev M. Shah in Eidos Therapeutics, Inc.
Trading Symbol: EIDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rajeev M. Shah: Director
Holdings: 1,103,847 shares
Latest Transaction: May 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Rajeev M. Shah in Eidos Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDTX, EIDX, KALA, KALV, RARX, STSA, SLDB
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2020 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 48.51 | 21,528 | 1,044,323 | 21,528 | |
Jun 13 2019 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
Jun 13 2019 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
Jul 03 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 20.34 | 43,056 | 875,759 | 43,056 | |
Jun 22 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 922,950 | 0 | 0 | |
Jun 22 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 2,162,671 | 1.1 M to 2.2 M (+95.92 %) |
Jun 22 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 1,103,847 | 0 | 1,103,847 | 0 to 1.1 M |
Page: 1